Report Code : CVMI24071656 | Published Date : July 16, 2024

The Cystic Fibrosis Therapeutics Market is experiencing significant growth, fueled by advancements in gene therapy, the development of CFTR modulators, and rising investment in precision medicine. Valued at USD 11.21 billion in 2023, the market is expected to grow at a CAGR of 14.75% from 2024 to 2031, ultimately reaching USD 33.69 billion by 2031.

Key Market Insights

Cystic fibrosis (CF) is a genetic disorder that affects the lungs and digestive system. It requires long-term treatment through pulmonary therapies, enzyme replacement, and emerging gene-editing technologies. The demand for targeted therapies and breakthrough CF drugs is increasing globally.

Growth Drivers

  • Advancements in CFTR Modulator Therapies: The introduction of triple-combination CFTR modulators is revolutionizing treatment outcomes.
  • Growing Investment in Gene Editing & RNA-Based CF Therapies – Research in CRISPR-Cas9 and RNA-based treatments is expanding therapeutic options.
  • Increased Adoption of Personalized and Precision Medicine Approaches – The emphasis on mutation-specific CF therapies is enhancing patient care outcomes.
  • Expanding the availability of CF care and multidisciplinary treatment centers—enhanced disease management strategies and specialized CF clinics are improving access to healthcare treatments.

 

Regional Trends

  • North America leads due to strong biotech research and FDA approvals for novel CF therapies.
  • Europe is expanding with government support for rare disease drug development.
  • Asia-Pacific is witnessing rapid growth, driven by increasing CF awareness and healthcare infrastructure improvements.
  • Latin America & MEA are emerging markets benefiting from international CF treatment collaborations.

 

Analyst View:

The Cystic Fibrosis Therapeutics Market is set for continuous expansion, driven by gene therapy breakthroughs, CFTR modulator advancements, and increasing funding for rare disease treatment research. Companies investing in personalized CF therapies, AI-driven drug development, and regenerative medicine applications will dominate this evolving sector.





Reasons To Buy

Image



Scope

Image

Key Players

  • Vertex Pharmaceuticals Incorporated
  • AbbVie Inc.
  • Gilead Sciences
  • Inc.
  • Novartis AG
  • Viatris Inc.

 

Cystic Fibrosis Therapeutics Market Report

  1. 1. Cystic Fibrosis Therapeutics Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Cystic Fibrosis Therapeutics Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
    2. Cystic Fibrosis Therapeutics Market Research Report - Preface
    1. 2.1 Cystic Fibrosis Therapeutics Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Drug Class
      2. 2.1.2 By Age Group
      3. 2.1.3 By Region
    3. Cystic Fibrosis Therapeutics Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Drug Class, By Age Group, By Country
    3. 3.3. Opportunities – By Drug Class, By Age Group, By Country
    4. 3.4. Trends – By Drug Class, By Age Group, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Cystic Fibrosis Therapeutics Market Research Report – DROTs Impact Analysis
    4. Cystic Fibrosis Therapeutics Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. Cystic Fibrosis Therapeutics Market, By Drug Class, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 CFTR Modulators
      1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 5.2 Bronchodilators
      1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 5.3 Mucolytics
      1. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 5.4 Antibiotics
      1. 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Cystic Fibrosis Therapeutics Market, By Age Group, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Pediatric
      1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 6.2 Adult
      1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Cystic Fibrosis Therapeutics Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 North America
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 7.2 Europe
      1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 7.3 Asia-Pacific
      1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 7.4 Latin America
      1. 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 7.5 Middle East & Africa
      1. 7.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 7.6 Cystic Fibrosis Therapeutics Market - Opportunity Analysis Index, By Drug Class, By Age Group, and Region, 2024 - 2031
    8. North America Cystic Fibrosis Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 By Drug Class Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.1.1 CFTR Modulators
      2. 8.1.2 Bronchodilators
      3. 8.1.3 Mucolytics
      4. 8.1.4 Antibiotics
      8.2 By Age Group Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.2.1 Pediatric
      2. 8.2.2 Adult
      8.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.3.1 United States
      2. 8.3.2 Canada
      8.4 North America Cystic Fibrosis Therapeutics Market – Opportunity Analysis Index, By Drug Class, By Age Group, and Country, 2024 - 2031
      8.5 Regional Trends Analysis
      8.6 North America Cystic Fibrosis Therapeutics Market Research Report - Company Profiles
      1. 8.6.1 Company 1 (United States)
      2. 8.6.2 Company 2 (Canada)
      3. 8.6.3 Company 3 (Canada)
    9. Europe Cystic Fibrosis Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 By Drug Class Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 CFTR Modulators
      2. 9.1.2 Bronchodilators
      3. 9.1.3 Mucolytics
      4. 9.1.4 Antibiotics
      9.2 By Age Group Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Pediatric
      2. 9.2.2 Adult
      9.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 Germany
      2. 9.3.2 United Kingdom
      3. 9.3.3 France
      4. 9.3.4 Spain
      5. 9.3.5 Italy
      6. 9.3.6 Russia
      7. 9.3.7 Netherlands
      8. 9.3.8 Poland
      9. 9.3.9 Rest of Europe
      9.4 Europe Cystic Fibrosis Therapeutics Market – Opportunity Analysis Index, By Drug Class, By Age Group, and Country, 2024 - 2031
      9.5 Regional Trends Analysis
      9.6 Europe Cystic Fibrosis Therapeutics Market Research Report - Company Profiles
      1. 9.6.1 Company 1 (Germany)
      2. 9.6.2 Company 2 (United Kingdom)
      3. 9.6.3 Company 3 (United Kingdom)
    10. Asia-Pacific Cystic Fibrosis Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 10.1 By Drug Class Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 CFTR Modulators
      2. 10.1.2 Bronchodilators
      3. 10.1.3 Mucolytics
      4. 10.1.4 Antibiotics
      10.2 By Age Group Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 Pediatric
      2. 10.2.2 Adult
      10.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 China
      2. 10.3.2 Japan
      3. 10.3.3 India
      4. 10.3.4 South Korea
      5. 10.3.5 Australia & NZ
      6. 10.3.6 ASEAN
      7. 10.3.7 Rest of Asia-Pacific
      10.4 Asia-Pacific Cystic Fibrosis Therapeutics Market – Opportunity Analysis Index, By Drug Class, By Age Group, and Country, 2024 - 2031
      10.5 Regional Trends Analysis
      10.6 Asia-Pacific Cystic Fibrosis Therapeutics Market Research Report - Company Profiles
      1. 10.6.1 Company 1 (China)
      2. 10.6.2 Company 2 (Japan)
      3. 10.6.3 Company 3 (Japan)
    11. Latin America Cystic Fibrosis Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 11.1 By Drug Class Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 CFTR Modulators
      2. 11.1.2 Bronchodilators
      3. 11.1.3 Mucolytics
      4. 11.1.4 Antibiotics
      11.2 By Age Group Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Pediatric
      2. 11.2.2 Adult
      11.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Brazil
      2. 11.3.2 Mexico
      3. 11.3.3 Argentina
      4. 11.3.4 Peru
      5. 11.3.5 Colombia
      6. 11.3.6 Rest of Latin America
      11.4 Latin America Cystic Fibrosis Therapeutics Market – Opportunity Analysis Index, By Drug Class, By Age Group, and Country, 2024 - 2031
      11.5 Regional Trends Analysis
      11.6 Latin America Cystic Fibrosis Therapeutics Market Research Report - Company Profiles
      1. 11.6.1 Company 1 (Brazil)
      2. 11.6.2 Company 2 (Mexico)
      3. 11.6.3 Company 3 (Mexico)
    12. Middle East & Africa Cystic Fibrosis Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 12.1 By Drug Class Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 CFTR Modulators
      2. 12.1.2 Bronchodilators
      3. 12.1.3 Mucolytics
      4. 12.1.4 Antibiotics
      12.2 By Age Group Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Pediatric
      2. 12.2.2 Adult
      12.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Saudi Arabia
      2. 12.3.2 UAE
      3. 12.3.3 South Africa
      4. 12.3.4 Egypt
      5. 12.3.5 Israel
      6. 12.3.6 Rest of Middle East and Africa
      12.4 Middle East & Africa Cystic Fibrosis Therapeutics Market – Opportunity Analysis Index, By Drug Class, By Age Group, and Country, 2024 - 2031
      12.5 Regional Trends Analysis
      12.6 Middle East & Africa Cystic Fibrosis Therapeutics Market Research Report - Company Profiles
      1. 12.6.1 Company 1 (Saudi Arabia)
      2. 12.6.2 Company 2 (UAE)
      3. 12.6.3 Company 3 (UAE)
    13. Competition Landscape
    1. 13.1 Strategic Dashboard of Top Market Players
      13.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 13.2.1 Vertex Pharmaceuticals Incorporated
      2. 13.2.2 AbbVie Inc.
      3. 13.2.3 Gilead Sciences
      4. 13.2.4 Inc.
      5. 13.2.5 Novartis AG
      6. 13.2.6 Viatris Inc.
    14. Data Collection Method and Research Approach
    15. Principal Presumptions and Acronyms




    2.  
  2.